Interleukin-18 binding protein is a novel glycoprotein that we successfully
cloned and expressed. First, murine interleukin-18 binding protein was pur
ified from the sera of mice with endotoxin shock using ligand affinity chro
matography. The murine interleukin-18 binding protein cDNA was cloned after
RT-PCR using mixed primer pair sequences based on partial murine interleuk
in-18 binding protein amino acid sequence analysis. Subsequently, human int
erleukin-18 binding protein cDNA was cloned from cDNA libraries of normal h
uman liver using murine interleukin-18 binding protein cDNA as a probe. Nex
t, we transiently expressed recombinant human and murine interleukin-18 bin
ding proteins in COS-1 cells and purified them from culture supernatants. B
oth recombinant interleukin-18 binding proteins did not exhibit species spe
cificity and prevented interleukin-18 binding to its receptor. In addition,
they inhibited interleukine-18 dependent IFN-gamma production from KG-1 ce
lls effectively. These results suggest that the interleukin-18 binding prot
ein may possess interleukine-18 antagonist activity. (C) 1999 Federation of
European Biochemical Societies.